Research & 6 Innovation 201 - ELRIG...Innovation TRENT VINEYARD, NOTTINGHAM 23rd March 2016 201 6...

Post on 07-Aug-2020

1 views 0 download

Transcript of Research & 6 Innovation 201 - ELRIG...Innovation TRENT VINEYARD, NOTTINGHAM 23rd March 2016 201 6...

BIOPHARMACEUTICALS: Room G2

Research &InnovationTRENT VINEYARD, NOTTINGHAM23rd March 2016

2016

#ELRIGRI16

www.elrig.org

Biopharmaceutical drugs continue to increase market share and fill the pipeline of major drug companies. This trend, which is predicted to increase even further, results in a highly competitive commercial and scientific landscape. As such, any improvements to the drug discovery process will be able to yield significant benefits both in terms of cost of goods and, for the benefit of patients, bringing new drugs to market more quickly.

Opening Remarks & Introduction of Keynote speaker

9:15 - 10:15

9:00 - 9:15

10:45 - 10:55

10:55 - 11:25

TIME

POSTER TASTERS

SNAPSHOT PRESENTATIONS

LUNCH - EXHIBITION - POSTERS

PLENARY KEYNOTE: ROOM F1

CLOSE OF CONFERENCE

SPEAKER TITLE

Mark Wigglesworth, AstraZenecaMike Jowett, Illumina

Overcoming Manufacturing Commercialisation Challenges for Cell and Gene TherapyStephen Ward

Cell Therapy Catapult

Opening RemarksSession Chairs

COFFEE BREAK (Exhibition & Posters)

COFFEE BREAK (Exhibition & Posters)

Chairs: Gary Pettman, MedImmune and David Krige, Immunocore

Discovering Novel Antibody Targets by Phenotypic Screening

Andrea Gonzalez-MunozMedImmune

Streamlining High-Throughput Flow Cytometry For the Drug Discovery Process

Stephen RapeckiUCB, Slough

Leveraging Smart Automation in the Biopharmaceutical Industry & the Dawn of Terrabyte Product Files

Will LewisGlaxoSmithKline

Tailoring CHO Cell Metabolism via microRNA Manipulation

Niall BarronIrish National Institute for Cellular Biotechnology (NICB)

ImmTACs: Changing the Therapeutic PerspectiveAndy JohnsonImmunocore

Developing Tumor-Localized, Combination Immunotherapies by Arming the Oncolytic Group B Adenovirus Enadenotucirev

Brian ChampionPsiOxus Therapeutics Ltd

Discovering and Developing Novel Anti-Cancer Biotherapeutics: The View From Cancer Research UK

James RitchieCancer Research UK (CRUK)

11:25 - 11:55

12:25 - 12:55

11:55 - 12:25

12:55 - 14:00

14:00 - 14:30

14:30 - 15:00

15:30 - 16:00

15:00 - 15:30

16:00 - 16:30

16:30 - 17:00

17:00 - 17:30

10:15 - 10:45

Vicky Day, BMG Labtech LtdAnna Groom, LabLogic

Donna Potts, AgilentSteve Davenport, IntelliCYT